“ … veterinary vaccines currently account for 26% of the global market in veterinary medicines, reflecting the importance of vaccines in animal health … In 2010, the number of food-producing animals was estimated to be roughly 20 billion and is rising gradually.”
Pastoret, Bull Acad Natl Med. 2012 Mar;196(3):589-90, 619-20

H1N1 has been a well-publicized influenza virus because a strain of it resulted in the 2009 pandemic that hospitalized 9,079 people and killed 593 between April and August in the United States alone. Although the first case of it in a pig was not confirmed until October of 2009, according to the CDC, the virus still exists in swine in the United States and is likely to continue to spread through pig-to-pig contact.

Through our Particle Precision Fabrication (PPF) technology, we are creating a single-injection, self-contained H1N1 vaccine formulation for swine. This formulation, when compared to existing vaccines on the market, will improve compliance and lower total vaccine administration costs.

Our H1N1 vaccine formulation aims to improve upon existing vaccines by aiding in compliance. The standard protocol for H1N1 vaccines currently on the market requires two subcutaneous injections, a primer followed by a booster 21 days later. Unless every animal receives both injections at the specified times, the risk for disease increases. Our H1N1 vaccine formulation requires only a single injection. When a farmer or veterinarian administers our formulation, there will be an initial release of vaccine, similar to the primer dose administration of existing H1N1 vaccines. After two weeks, there will be a delayed pulse of vaccine release, and 80% of the microencapsulated vaccine will release within 48 hours. Because the delayed-pulse design of our formulation eliminates the need for multiple injections, compliance should increase, which should reduce the risk of disease.

Another way our H1N1 vaccine formulation will improve vaccines currently on the market is through lower cost. The price of vaccinating livestock is not limited to that of the vaccine itself. Often, a much larger cost is the cost of handling the animal. When a vaccine requires multiple injections, farmers must pay for vaccine administrator handling the animal on multiple occasions. If transportation is involved, farmers must pay for transportation multiple times. With our single-injection H1N1 vaccine formulation, a farmer only needs to pay for syringes, animal handling and transportation once.

Created with PPF technology, our single-injection, self-contained H1N1 vaccine formulation aims to improve upon existing vaccines on the market by encouraging compliance and lowering costs. In 2009, a strain of H1N1 made the news as a deadly pandemic. With the addition of our H1N1 vaccine formulation to those currently on the market, we hope H1N1 will make the news again, this time for being eradicated from swine.